{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:06:17Z","timestamp":1785305177371,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05335-z","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:04:37Z","timestamp":1767866677000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular and genetic insights into vestibular schwannoma"],"prefix":"10.1007","volume":"176","author":[{"given":"Yosef","family":"Ellenbogen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P.","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leeor S.","family":"Yefet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parsa Babaei","family":"Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Nassiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelareh","family":"Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"5335_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1056\/NEJMra2020394","volume":"384","author":"ML Carlson","year":"2021","unstructured":"Carlson ML, Link MJ (2021) Vestibular Schwannomas. NEJM Evid 384:1335\u20131348","journal-title":"NEJM Evid"},{"key":"5335_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11060-015-1827-9","volume":"124","author":"VR Kshettry","year":"2015","unstructured":"Kshettry VR, Hsieh JK, Ostrom QT, Kruchko C, Barnholtz-Sloan JS (2015) Incidence of vestibular schwannomas in the United States. J Neurooncol 124:223\u2013228","journal-title":"J Neurooncol"},{"key":"5335_CR3","doi-asserted-by":"crossref","unstructured":"Yao L, Alahmari M, Temel Y, Hovinga K (2020) Therapy of sporadic and NF2-related vestibular schwannoma. Cancers (Basel) 12","DOI":"10.3390\/cancers12040835"},{"key":"5335_CR4","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1007\/s12105-020-01155-x","volume":"14","author":"VK Gupta","year":"2020","unstructured":"Gupta VK, Thakker A, Gupta KK (2020) Vestibular schwannoma: what we know and where we are heading. Head Neck Pathol 14:1058\u20131066","journal-title":"Head Neck Pathol"},{"key":"5335_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/hmg\/3.1.147","volume":"3","author":"EC Twist","year":"1994","unstructured":"Twist EC et al. (1994) The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3:147\u2013151","journal-title":"Hum Mol Genet"},{"key":"5335_CR6","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1101\/gad.1335605","volume":"19","author":"AI McClatchey","year":"2005","unstructured":"McClatchey AI, Giovannini M (2005) Membrane organization and tumorigenesis\u2013the NF2 tumor suppressor, Merlin. Genes Dev 19:2265\u20132277","journal-title":"Genes Dev"},{"key":"5335_CR7","doi-asserted-by":"publisher","first-page":"e860","DOI":"10.1097\/MAO.0000000000001932","volume":"39","author":"ML Carlson","year":"2018","unstructured":"Carlson ML et al. (2018) Next generation sequencing of sporadic vestibular schwannoma: necessity of Biallelic NF2 inactivation and implications of accessory non-NF2 variants. Otol Neurotol 39:e860\u2013e871","journal-title":"Otol Neurotol"},{"key":"5335_CR8","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/ng.3688","volume":"48","author":"S Agnihotri","year":"2016","unstructured":"Agnihotri S et al. (2016) The genomic landscape of schwannoma. Nat Genet 48:1339\u20131348","journal-title":"Nat Genet"},{"key":"5335_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41467-023-42762-w","volume":"15","author":"TF Barrett","year":"2024","unstructured":"Barrett TF et al. (2024) Single-cell multi-omic analysis of the vestibular schwannoma ecosystem uncovers a nerve injury-like state. Nat Commun 15:478","journal-title":"Nat Commun"},{"key":"5335_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41467-023-40408-5","volume":"15","author":"SJ Liu","year":"2024","unstructured":"Liu SJ et al. (2024) Epigenetic reprogramming shapes the cellular landscape of schwannoma. Nat Commun 15:476","journal-title":"Nat Commun"},{"key":"5335_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/neuonc\/not242","volume":"16","author":"M Giovannini","year":"2014","unstructured":"Giovannini M et al. (2014) mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma. Neuro Oncol 16:493\u2013504","journal-title":"Neuro Oncol"},{"key":"5335_CR12","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.bbrc.2005.12.122","volume":"340","author":"JY Lim","year":"2006","unstructured":"Lim JY, Kim H, Jeun S-S, Kang S-G, Lee K-J (2006) Merlin inhibits growth hormone-regulated Raf-ERKs pathways by binding to Grb2 protein. Biochem Biophys Res Commun 340:1151\u20131157","journal-title":"Biochem Biophys Res Commun"},{"key":"5335_CR13","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1093\/brain\/awac342","volume":"146","author":"L Laraba","year":"2022","unstructured":"Laraba L et al. (2022) Inhibition of YAP\/TAZ-driven tead activity prevents growth of NF2-null schwannoma and meningioma. Brain 146:1697\u20131713","journal-title":"Brain"},{"key":"5335_CR14","doi-asserted-by":"crossref","unstructured":"Chen Z et al. Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS\/MAPK signaling. JCI Insight 5:e141514","DOI":"10.1172\/jci.insight.141514"},{"key":"5335_CR15","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/322644a0","volume":"322","author":"BR Seizinger","year":"1986","unstructured":"Seizinger BR, Martuza RL, Gusella JF (1986) Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 322:644\u2013647","journal-title":"Nature"},{"key":"5335_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11060-021-03796-6","volume":"154","author":"P Taule-Sivertsen","year":"2021","unstructured":"Taule-Sivertsen P et al. (2021) The SH3PXD2A-HTRA1 fusion transcript is extremely rare in Norwegian sporadic vestibular schwannoma patients. J Neurooncol 154:35\u201340","journal-title":"J Neurooncol"},{"key":"5335_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11060-022-04221-2","volume":"161","author":"AP Landry","year":"2023","unstructured":"Landry AP, Wang JZ, Suppiah S, Zadeh G (2023) Multiplatform molecular analysis of vestibular schwannoma reveals two robust subgroups with distinct microenvironment. J Neurooncol 161:491\u2013499","journal-title":"J Neurooncol"},{"key":"5335_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/neuonc\/noad201","volume":"26","author":"Z Huo","year":"2024","unstructured":"Huo Z et al. (2024) Single-cell transcriptomes reveal the heterogeneity and microenvironment of vestibular schwannoma. Neuro Oncol 26:444\u2013457","journal-title":"Neuro Oncol"},{"key":"5335_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1056\/NEJMoa0902579","volume":"361","author":"SR Plotkin","year":"2009","unstructured":"Plotkin SR et al. (2009) Hearing improvement after Bevacizumab in patients with neurofibromatosis type 2. NEJM Evid 361:358\u2013367","journal-title":"NEJM Evid"},{"key":"5335_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40478-025-01937-w","volume":"13","author":"T Tsuchiya","year":"2025","unstructured":"Tsuchiya T et al. (2025) Current molecular understanding of central nervous system schwannomas. Acta Neuropathol Commun 13:24","journal-title":"Acta Neuropathol Commun"},{"key":"5335_CR21","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3171\/2019.7.JNS19879","volume":"133","author":"A Perry","year":"2020","unstructured":"Perry A et al. (2020) Predominance of M1 subtype among tumor-associated macrophages in phenotypically aggressive sporadic vestibular schwannoma. J Neurosurg 133:1637\u20131645","journal-title":"J Neurosurg"},{"key":"5335_CR22","doi-asserted-by":"publisher","first-page":"8335","DOI":"10.2147\/JIR.S476745","volume":"17","author":"J Gan","year":"2024","unstructured":"Gan J et al. (2024) Exploring the role of inflammatory genes and immune infiltration in vestibular schwannomas pathogenesis. J Inflamm Res 17:8335\u20138353","journal-title":"J Inflamm Res"},{"key":"5335_CR23","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1097\/MAO.0000000000000788","volume":"36","author":"M de Vries","year":"2015","unstructured":"de Vries M, van der Mey AGL, Hogendoorn PCW (2015) Tumor biology of Vestibular Schwannoma: a review of experimental data on the determinants of tumor genesis and growth characteristics. Otol Neurotol 36:1128\u20131136","journal-title":"Otol Neurotol"},{"key":"5335_CR24","doi-asserted-by":"publisher","first-page":"fcad197","DOI":"10.1093\/braincomms\/fcad197","volume":"5","author":"GE Gregory","year":"2023","unstructured":"Gregory GE et al. (2023) The comparable tumour microenvironment in sporadic and NF2-related schwannomatosis vestibular schwannoma. Brain Commun 5:fcad197","journal-title":"Brain Commun"},{"key":"5335_CR25","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.ajpath.2022.06.006","volume":"192","author":"M Xu","year":"2022","unstructured":"Xu M et al. (2022) Single-cell RNA-Seq reveals heterogeneity of cell communications between Schwann cells and fibroblasts within vestibular schwannoma microenvironment. Am J Pathol 192:1230\u20131249","journal-title":"Am J Pathol"},{"key":"5335_CR26","doi-asserted-by":"crossref","unstructured":"Ren Y, Chari DA, Vasilijic S, Welling DB, Stankovic KM (2020) New developments in neurofibromatosis type 2 and vestibular schwannoma. Neurooncol Adv 3, vdaa153","DOI":"10.1093\/noajnl\/vdaa153"},{"key":"5335_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41698-024-00627-5","volume":"8","author":"D Xu","year":"2024","unstructured":"Xu D, Yin S, Shu Y (2024) NF2: an underestimated player in cancer metabolic reprogramming and tumor immunity. npj Precis. Onc 8:1\u201317","journal-title":"npj Precis. Onc"},{"key":"5335_CR28","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","volume":"24","author":"SR Plotkin","year":"2022","unstructured":"Plotkin SR et al. (2022) Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation. Genet in Med 24:1967\u20131977","journal-title":"Genet in Med"},{"key":"5335_CR29","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.3390\/cancers12092355","volume":"12","author":"I Gugel","year":"2020","unstructured":"Gugel I et al. (2020) Age at onset and presenting symptoms of neurofibromatosis type 2 as prognostic factors for clinical course of vestibular schwannomas. Cancers (Basel) 12:2355","journal-title":"Cancers (basel)"},{"key":"5335_CR30","doi-asserted-by":"publisher","first-page":"e529","DOI":"10.1097\/MAO.0000000000002613","volume":"41","author":"CT Dinh","year":"2020","unstructured":"Dinh CT et al. (2020) Genomics, Epigenetics, and hearing loss in neurofibromatosis type 2. Otol Neurotol 41:e529\u2013e537","journal-title":"Otol Neurotol"},{"key":"5335_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1399-0004.2009.01315.x","volume":"77","author":"S Selvanathan","year":"2010","unstructured":"Selvanathan S et al. (2010) Further genotype \u2013 phenotype correlations in neurofibromatosis 2. Clin Genet 77:163\u2013170","journal-title":"Clin Genet"},{"key":"5335_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmedgenet-2017-104519","volume":"54","author":"D Halliday","year":"2017","unstructured":"Halliday D et al. (2017) Genetic severity score predicts clinical phenotype in NF2. J Med Genet 54:657\u2013664","journal-title":"J Med Genet"},{"key":"5335_CR33","doi-asserted-by":"publisher","first-page":"5470","DOI":"10.1038\/s41598-017-05769-0","volume":"7","author":"H Chen","year":"2017","unstructured":"Chen H, Xue L, Wang H, Wang Z, Wu H (2017) Differential NF2 gene status in sporadic vestibular schwannomas and its prognostic impact on tumour growth patterns. Sci Rep 7:5470","journal-title":"Sci Rep"},{"key":"5335_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/gepi.10238","volume":"24","author":"R Woods","year":"2003","unstructured":"Woods R, Friedman JM, Evans DGR, Baser ME, Joe H (2003) Exploring the \u2018two-hit hypothesis\u2019 in NF2: tests of two-hit and three-hit models of vestibular schwannoma development. Genet Epidemiol 24:265\u2013272","journal-title":"Genet Epidemiol"},{"key":"5335_CR35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/jmedgenet-2015-103050","volume":"52","author":"SM Stivaros","year":"2015","unstructured":"Stivaros SM et al. (2015) Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis type 2. J Med Genet 52:557\u2013562","journal-title":"J Med Genet"},{"key":"5335_CR36","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","volume":"23","author":"R Goldbrunner","year":"2021","unstructured":"Goldbrunner R et al. (2021) Eano guideline on the diagnosis and management of meningiomas. Neuro Oncol 23:1821\u20131834","journal-title":"Neuro Oncol"},{"key":"5335_CR37","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000003426","author":"BA Strickland","year":"2025","unstructured":"Strickland BA, Honaker JA, Olson JJ (2025) Congress of neurological surgeons systematic review and evidence-based guidelines update for the role of audiologic screening in the diagnosis and management of patients with vestibular schwannomas. Neurosurgery.https:\/\/doi.org\/10.1227\/neu.0000000000003426.)","journal-title":"Neurosurgery"},{"key":"5335_CR38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s40136-021-00341-x","volume":"9","author":"H Jia","year":"2021","unstructured":"Jia H, Lahlou G, Wu H, Sterkers O, Kalamarides M (2021) Management of neurofibromatosis type 2 associated vestibular schwannomas. Curr Otorhinolaryngol Rep 9:170\u2013176","journal-title":"Curr Otorhinolaryngol Rep"},{"key":"5335_CR39","doi-asserted-by":"crossref","unstructured":"Evans DG et al. (2023) Radiation treatment of benign tumors in NF2-related-schwannomatosis: a national study of 266 irradiated patients showing a significant increase in malignancy\/malignant progression. Neurooncol Adv 5, vdad025","DOI":"10.1093\/noajnl\/vdad025"},{"key":"5335_CR40","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1186\/s12885-025-13959-7","volume":"25","author":"B Hajikarimloo","year":"2025","unstructured":"Hajikarimloo B et al. (2025) Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2: a systematic review and meta-analysis. BMC Cancer 25:698","journal-title":"BMC Cancer"},{"key":"5335_CR41","doi-asserted-by":"crossref","unstructured":"Chiranth S, Langer SW, Poulsen HS, Urup T (2023) A systematic review of targeted therapy for vestibular schwannoma in patients with NF2-related schwannomatosis. Neuro-Oncol Adv 5, vdad099","DOI":"10.1093\/noajnl\/vdad099"},{"key":"5335_CR42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12307-018-0216-2","volume":"11","author":"PS Ariyannur","year":"2018","unstructured":"Ariyannur PS, Vikkath N, Pillai AB (2018) Cerebrospinal fluid hyaluronan and neurofibromatosis type 2. Cancer Microenviron 11:125\u2013133","journal-title":"Cancer Microenviron"},{"key":"5335_CR43","doi-asserted-by":"crossref","unstructured":"Edvardsson Rasmussen J, Li P, Laurell G, Bergquist J, E (2024) Hearing loss and its association with the proteome of perilymph, cerebrospinal fluid, and tumor tissue in patients with vestibular schwannoma. Sci Rep 14:14118","DOI":"10.1038\/s41598-024-64352-6"},{"key":"5335_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.omtm.2022.06.012","volume":"26","author":"S Prabhakar","year":"2022","unstructured":"Prabhakar S et al. (2022) Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2. Mol Ther Methods Clin Dev 26:169\u2013180","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05335-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05335-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05335-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:47:08Z","timestamp":1769773628000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05335-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5335"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05335-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This review was in accordance with all relevant guidelines and regulations. No experimentation on human or animals were done.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}